FindTrial
Sign In

Study to Compare and evaluate better glycemic control in diabetic and non-diabetic patients.

Study to Compare and evaluate the Glycemic index of commercially available breakfast food items related to its effect in achieving better glycemic control in diabetic and non-diabetic patients.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/11/021946
Enrollment
80
Registered
2019-11-11
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Dal Idli Dal Dosa Dal Chapathi Keto Roti : A set of 80 participants are Randomized to the study. Whose anthropometric and physiological measurements like age, height, weight, BMI, waist

Sponsors

Bangalore Diabetes Centre
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Type II Diabetes Mellitus and Non diabetic subjects of either sex aged 18 to 60years. 2.Type II Diabetes Mellitus subjects with duration less than 5 years. 3.Subjects able to provide written informed consent. 4.Subjects without any antidiabetic medication or on metformin as monotherapy 5.Agree to follow the study prodecures and adhere to visits. 6.If female of childbearing age, willing to use an acceptable form of birth control measure, should be stable for past 3 months prior to baseline and throughout the study.

Exclusion criteria

Exclusion criteria: 1.Subjects with deteriorating health status at the time of enrolment; rapid weight loss, terminal disease, significant chronic disease (e.g., chronic diarrhea, gastro-intestinal disease, irritable bowel syndrome). 2.Type II Diabetes Mellitus subjects with duration more than 5 years. 3.Recent blood donation (within 3 months from the date of screening). 4.Immunodeficiency disease (e.g., human immunodeficiency virus [HIV] infection). 5.Pregnant or breast feeding women. 6.Currently participating or having participated in another clinical trial during the last 3 months prior to the beginning of this study. 7.Conditions in the opinion of the investigator make the patient unsuitable to participate in the study . 8.Any contraindication to blood sampling. 9.Subjects with history of nephropathy/Renal dysfunction.

Design outcomes

Primary

MeasureTime frame
To compare the glycemic levels ( FBG, PPBS) in type II diabetes patients and non diabetic subjects.Timepoint: 0 m, 15m, 30m,45m, 60m, 90m,120m, 150m,180m.—

Secondary

MeasureTime frame
Change in glycemic indexTimepoint: From baseline to end of study—

Countries

India

Contacts

Public ContactDr Paramesh S

Bangalore Diabetes Centre

drparamesh2@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026